IAM Magazine issue 22February/March 2007
It has always been important to be sure that the IP you are acquiring is the IP you want. However, the growing number of ways in which rights can now be monetised means that due diligence is more vital than ever before.
There are a number of issues that companies would do well to consider before they accept funds from the US government for R&D
Patent values in the US, as determined by the top 25 litigation awards/settlements, took a tumble in 2006, dropping from US$5.1 million to US$3.1 million.
It is the forensic science that for many companies has played a key role in turning patents into revenue. And now reverse engineering is more sophisticated than it has ever been before.
Although many of those urging patent reform in the US say they want to increase competition and innovation, what they are proposing could, in fact, have the very opposite effect.
Although IP ownership can be hugely beneficial, it does bring with it risks of certain downsides, from assertions by patent trolls through to potential shareholder suits. A recent survey suggests that certain types of insurance could help to mitigate such risks
Instead of leaving unused and unwanted intellectual property rights to wither on the vine, companies should think carefully about whether they are suitable candidates to provide the launchpad for a corporate spinout
From Messrs Fredrik Kjell, Jonas Lindgren, Erik Malm, Henrik Pettersson and Anders Sundelin.
It was probably the biggest IP get-together in Europe since the INTA held its annual meeting in Amsterdam in 2003. And the pan-European IP Summit was dominated by talk of the continuing impasse in attempts to reform the continent’s patent system.
The much-heralded Gowers Report was not well received by the UK’s music industry. But the industry is wrong and Gowers is right.
A new initiative aimed at standardising the way in which patents are valued should be embraced by the business and patent communities
Investing in the creation of IP is like investing in the property market. You have to know what you are doing if you are to succeed
It is no secret that amicus filers are not always interested in the general cause of justice.
With their recent MedImmune v Genentechjudgment, the nine Supreme Court justices have changed the licensing landscape in the US
Co-published editorialIndustry insight
Is the study of patents and patenting trends just a passing fad and are companies really benefiting from patent analytics? CPA's Rahul Jindal and Bianca McDonogh investigate
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email